Congress funds alternative protein research with $100M over five years
H.R. 6780 — Producing Real Opportunities for Technology and Entrepreneurs Investing in Nutrition Act · Filed by Julia Brownley (D-CA) · 17 cosponsors · Introduced Dec 17, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill directs the U.S. Department of Agriculture to establish research centers and grant programs focused on developing alternative protein sources through bioprocessing and biomanufacturing—using underutilized plant materials to create food proteins at scale. It authorizes $100 million over five years (2026–2030) for research centers, workforce training, commercial facility grants, and a national strategy coordinating multiple federal agencies. The bill aims to diversify the U.S. protein supply, create jobs, strengthen food security, and position America as a global leader in food innovation.
Why we flagged it
The bill's core mechanism is direct federal funding for research, workforce development, and commercial-scale facility grants in alternative protein production. It is a straightforward public investment in an emerging agricultural biotechnology sector, not a deregulation, subsidy carve-out, or liability shield.
What the text implies
- Grant eligibility extends to for-profit companies with minimal U.S. ownership threshold (51%), potentially allowing foreign-controlled entities to capture federal funds if structured as U.S. subsidiaries.
- The bill funds both research AND commercial-scale production facilities, blurring the line between basic research (traditional USDA role) and private industrial capacity—may create dependency on federal support for private manufacturers.
- National strategy involves 9 federal agencies (Defense, Energy, Commerce, NSF, NIH, FDA, CDC, EPA, OSTP), creating coordination complexity and potential for conflicting priorities or duplicative spending.
- No explicit performance metrics, clawback provisions, or sunset clauses tied to job creation or supply-chain outcomes—$100M commitment with limited accountability mechanisms.
- Explicit exclusion of insect-based protein (Section 9) may signal political sensitivity but also narrows the scope of 'alternative protein' innovation the bill nominally supports.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
The bill funds research and workforce development in an emerging sector with potential to improve food security, create jobs, and diversify protein sources—all public goods. While private companies are eligible for grants, the funding is conditional on demonstrated capability and U.S. ownership/control, and the underlying research advances a legitimate national interest (supply chain resilience, food security, job creation). No existing protections or rights are restricted.
Who stands to gain
- for-profit food biomanufacturing companies
- nonprofit research institutions and universities
- agricultural biotechnology startups
- workforce development organizations
- construction and engineering firms (facility retrofitting/expansion)
Named in the bill
U.S. Department of Agriculture (USDA), Agricultural Research Service (ARS), 1890 Institutions (historically Black colleges and universities in agriculture), National Laboratories, Department of Defense, Department of Energy, Department of Commerce, National Science Foundation (NSF), National Institutes of Health (NIH), Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), Environmental Protection Agency (EPA) — and 1 more
Where it stands
17 cosponsors: 17 Democrats.
- Dec 17, 2025 — Introduced · Congress.gov: “Introduced in House”
- Dec 17, 2025 — Referred to House Committee on Education and Workforce and House Committee on Agriculture · Congress.gov: “Referred to the Committee on Agriculture, and in addition to the Committee on Education and Workforce, for a…”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
Money around this bill
1 lobbying clients named this bill on 1 disclosure filings across 1 quarter, Jun 2026 to Jun 2026. Those filings disclosed $180,000 in lobbying spend. A filing names 9 bills on average, so that figure is what each filing reported, not a share belonging to this bill.
More lobbying clients named this bill than 0% of bills with at least one filing.
Julia Brownley, the sponsor, reported $296,500 in PAC receipts in the 2026 cycle.
- Food Solutions Action — $180,000 on 1 filing
Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (11,983 characters) on Jun 3, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
Money — Senate Lobbying Disclosure Act filings whose specific-issue field names this bill for quarters ending Jun 2026 to Jun 2026. A filing's amount is reported whole beside the median number of bills a filing names; it is never divided across them. PAC receipts are FEC-reported contributions to the sponsor's candidate committee in the 2026 cycle.
As of — lobbying records through Jul 20, 2026 · page rendered 2026-10-20.
“Congress funds alternative protein research with $100M over five years” QuorumCivic. https://share.quorumcivic.app/bill/119/hr6780 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.